SYN-004: Clinical Trials

3 trials of SYN-004, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Active not recruiting 1
Phase 12Active not recruiting 1, Completed 1

Follow SYN-004: new trials by email Literature Review of SYN-004 trials Research Report on SYN-004

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SYN-004 Safety and Tolerability in Allo-HCT Subjects
SYN-004, Ribaxamase or Placebo - Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics
Phase 1 / Phase 2Active not recruitingTheriva Biologics, Inc.362021-02-152026-03-17
A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI
SYN-004, Placebo - Clostridium Difficile, Clostridium Infections
Phase 2CompletedTheriva Biologics, Inc.4132015-10-012018-11-27
A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy
SYN-004, Esomeprazole, Ceftriaxone - Healthy Volunteers With Ileostomy
Phase 1 / Phase 2CompletedTheriva Biologics, Inc.152015-06-012018-11-27

Conditions studied

Clostridium Infections (1)

Sponsors

Theriva Biologics, Inc. (3)

Countries

Canada (2)  ·  United States (2)  ·  Bulgaria (1)  ·  Hungary (1)  ·  Poland (1)  ·  Romania (1)  ·  Serbia (1)

Top investigators

Michael Kaleko, MD (1)

Results publications

PMID 28052855, PMID 30885591